These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29861595)

  • 21. NF-κB is activated from endosomal compartments in antiphospholipid antibodies-treated human monocytes.
    Brandt KJ; Fickentscher C; Boehlen F; Kruithof EK; de Moerloose P
    J Thromb Haemost; 2014 May; 12(5):779-91. PubMed ID: 24612386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune thyroid disease and antiphospholipid antibodies.
    Nabriski D; Ellis M; Ness-Abramof R; Shapiro M; Shenkman L
    Am J Hematol; 2000 May; 64(1):73-5. PubMed ID: 10815793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
    Dayama A; Dass J; Mahapatra M; Saxena R
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-phospholipid Antibody Syndrome Presenting as Huge Ascites: A Case Report.
    Khan AH; Rahman MM; Rahaman MF; Rahman M; Mondal MK; Chowdhury MA
    Mymensingh Med J; 2018 Oct; 27(4):883-887. PubMed ID: 30487510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary anti-phospholipid antibody syndrome (APS): current concepts.
    Durrani OM; Gordon C; Murray PI
    Surv Ophthalmol; 2002; 47(3):215-38. PubMed ID: 12052409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female.
    Sung J; Anjum S
    Cureus; 2020 Jun; 12(6):e8408. PubMed ID: 32509485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.
    Kelchtermans H; Pelkmans L; de Laat B; Devreese KM
    J Thromb Haemost; 2016 Aug; 14(8):1530-48. PubMed ID: 27279342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptors involved in cell activation by antiphospholipid antibodies.
    Brandt KJ; Kruithof EK; de Moerloose P
    Thromb Res; 2013 Oct; 132(4):408-13. PubMed ID: 24054056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.
    Ochoa E; Iriondo M; Manzano C; Fullaondo A; Villar I; Ruiz-Irastorza G; Zubiaga AM; Estonba A
    PLoS One; 2016; 11(1):e0146990. PubMed ID: 26820623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
    Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
    Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibody syndrome: coexistence of left ventricular apical thrombus and deep vein thrombosis causing pulmonary thromboembolism in a patient with systemic lupus erythematosus.
    Acikel S; Akdemir R; Dogan M; Kilic H; Yesilay AB
    Echocardiography; 2010 Feb; 27(2):198-201. PubMed ID: 20113328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary antiphospholipid syndrome.
    Alarcón-Segovia D; Sanchez-Guerrero J
    J Rheumatol; 1989 Apr; 16(4):482-8. PubMed ID: 2746588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia.
    Bidot CJ; Jy W; Horstman LL; Ahn ER; Bidot L; Fontana V; Ahn YS
    Hematology; 2005 Dec; 10(6):451-6. PubMed ID: 16321809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
    Dima A; Caraiola S; Jurcut C; Balanescu E; Balanescu P; Ramba D; Badea C; Pompilian V; Ionescu R; Baicus A; Baicus C; Dan GA
    Rom J Intern Med; 2015; 53(4):321-8. PubMed ID: 26939208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical characteristics of anti-phospholipid antibodies].
    Shimmyozu K; Okadome T; Maruyama Y; Kadokura N; Maruyama I; Osame M; Tara M
    Rinsho Ketsueki; 1990 May; 31(5):633-8. PubMed ID: 2118574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomic distribution of venous thrombosis in patients with antiphospholipid antibody: imaging findings.
    Provenzale JM; Ortel TL
    AJR Am J Roentgenol; 1995 Aug; 165(2):365-8. PubMed ID: 7618558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral Venous Sinus Thrombosis in Systemic Lupus Erythematosus.
    Darmawan G; Hamijoyo L; Oehadian A; Bandiara R; Amalia L
    Acta Med Indones; 2018 Oct; 50(4):343-345. PubMed ID: 30631001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.
    Soltész P; Veres K; Lakos G; Kiss E; Muszbek L; Szegedi G
    Lupus; 2003; 12(4):302-7. PubMed ID: 12729054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.